Konishi M, Hashimoto H
Shionogi Research Laboratories, Shionogi & Company, Ltd., Osaka, Japan.
J Pharm Sci. 1990 May;79(5):379-83. doi: 10.1002/jps.2600790503.
A convenient and sensitive analytical method for determination of plasma morphine and its metabolites in cancer patients was established using HPLC with a column-switching technique. Sample plasma which has been deproteinized with trichloroacetic acid is injected onto a precolumn, then the compounds of interest are preferentially introduced into the analytical column for separation and detection after washing out the unnecessary plasma components from the precolumn. Detection was simultaneously performed with coulometry for unchanged morphine and morphine-6-glucuronide and with UV analysis for morphine-3-glucuronide. Analytical recoveries were greater than 99% for these compounds, and the averaged coefficients of within-day or between-day variation did not exceed 5.5%. Detection limits were 0.2 ng/mL for morphine, 0.5 ng/mL for morphine-6-glucuronide, and 10 ng/mL for morphine-3-glucuronide. Correlation between the previously reported solid extraction method and this method was satisfactory in plasma samples after administration of morphine.
采用柱切换技术的高效液相色谱法建立了一种简便、灵敏的分析方法,用于测定癌症患者血浆中吗啡及其代谢物。用三氯乙酸脱蛋白后的样品血浆注入预柱,然后在从预柱洗脱出不必要的血浆成分后,将感兴趣的化合物优先引入分析柱进行分离和检测。对未变化的吗啡和吗啡-6-葡萄糖醛酸苷同时进行库仑法检测,对吗啡-3-葡萄糖醛酸苷进行紫外分析检测。这些化合物的分析回收率均大于99%,日内或日间变异系数平均值不超过5.5%。吗啡的检测限为0.2 ng/mL,吗啡-6-葡萄糖醛酸苷的检测限为0.5 ng/mL,吗啡-3-葡萄糖醛酸苷的检测限为10 ng/mL。在给予吗啡后的血浆样品中,先前报道的固相萃取法与本法之间的相关性良好。